Schedule of Investor Meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has disclosed upcoming investor meetings scheduled for June 4, 2026. A group meeting arranged by Bank of America (BofA) and a separate one-on-one meeting with Emkay Global are planned. This is a routine regulatory filing under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30). The company has stated the schedule may change due to exigencies. The filing date is May 29, 2026, signed by the Company Secretary.
This is a routine disclosure with no direct impact on the stock. However, meetings arranged by major institutions like BofA indicate ongoing institutional interest in the company. No material price-sensitive information is being disclosed.